🇺🇸 FDA
Patent

US 7851169

Compositions and methods for inhibiting squamous cell carcinoma

granted A61KA61K2039/505A61P

Quick answer

US patent 7851169 (Compositions and methods for inhibiting squamous cell carcinoma) held by The United States of America as represented by the Department of Veterans Affairs Office of the General Counsel expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Department of Veterans Affairs Office of the General Counsel
Grant date
Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61P, A61P17/00, A61P35/00